Global Respiratory

Inhaler Devices
Market
Share, Global Trends,
Analysis, Research, Report,
Opportunities,
Segmentation and Forecast,
2015

Future Market Insights

www.futuremarketinsights.com

sales@futuremarketinsights.com

Future Market Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting
services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes,
technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends.
We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC.
Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and
Retail.
We have a global presence with delivery centers across India specializing in providing global research reports and country
research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India.
We combine our knowledge and learning from every corner of the world to distill it to one thing the perfect solution for
our client.

Research Capabilities

Sector Coverage

Customized Research
Syndicated Research
Investment Research
Social Media Research

Automotive and Transportation

Electronics, Semiconductor, and ICT
Retail and Consumer Products
Industrial Automation and Equipment

Customized
Research

Subscription Information

Syndicated
Research

For detailed subscription information please contact

Investment
Research

T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268

Social Media
Research

Hari. T (Sr. Manager - Global Business Development)

Email: hari.t@futuremarketinsights.com

Chemicals & Materials

Food and Beverages
Services and Utilities
Energy, Mining, Oil, and Gas

Report
Description
Report Description
Respiratory inhaler is a device that delivers a specific amount of medication to the lungs,
in the form of a short burst of aerosolized medicine that is usually self-administered by
the patient via inhalation.

It is the most commonly used medication delivery system for treating Asthma, Chronic
Obstructive Pulmonary Disease (COPD) and other respiratory diseases. Asthma is a
common chronic inflammatory disease of the airways characterized by variable and
recurring symptoms, reversible airflow obstruction and bronchospasm. Common
symptoms include wheezing, coughing, chest tightness, and shortness of breath.
Whereas, COPD is the obstructive lung disease characterized by chronically poor airflow.
It typically worsens over time. The main symptoms include shortness of breath, cough,
and sputum production. Most people with chronic bronchitis have COPD. The primary
cause of COPD is tobacco smoke (through tobacco use or second-hand smoke).
As per WHO, Some 235 million people currently suffer from asthma and more than 3
million people died of COPD in 2012, which is equal to 6% of all deaths globally that year.

Respiratory Inhaler Devices Market: Drivers and Restraints

The respiratory inhaler devices market is driven by aging population and increasing
respiratory disease among global population.
Respiratory inhaler devices market will be driven by new technological advancements.
The huge population afflicted with respiratory disorders such as asthma and chronic
obstructive pulmonary disease will drive the Respiratory inhaler market.

Report
Description
Report Description
Browse Full Report@ http://www.futuremarketinsights.com/reports/respiratoryinhaler-devices-market
Increasing focus among pediatric patients with COPD and Asthma. Also, awareness
programmes by healthcare organization to increase adoption rate will drive this market.
However, it is observed that the respiratory inhalers, particularly Metered Dose Inhaler
(MDIs), release environmentally-hazardous gases, namely chlorofluorocarbon (CFC) and
hydrofluoroalkanes (HFA), which is acting as a barrier in the adoption of such devices.
Respiratory Inhaler Devices Market: Segmentation

The global respiratory inhaler devices market is segmented into following devices:
Dry Powder Inhalers
Metered Dose Inhaler
Nebulizers

Considering the growth and market size, Metered Dose Inhalers (MDIs) are the largest
revenue generating segment currently and is expected to grow at a higher rate in the
forecast period.
Respiratory Inhaler Devices Market: Overview
With rapid technological advancement and wide acceptance of respiratory inhaler
devices among patients with respiratory disorder, the global respiratory inhaler market is

Report
Description
Report Description
Request Report TOC@ http://www.futuremarketinsights.com/toc/rep-gb-493
Respiratory Inhaler Devices Market: Regional Outlook
The global respiratory inhaler devices market is expected to register a significant growth
for the forecast period. Depending on geographic regions, the global respiratory inhaler
devices market is segmented into seven key regions: North America, South America,
Eastern Europe, Western Europe, Asia Pacific, Japan, and Middle East & Africa. North
America is the largest market for respiratory inhaler devices, followed by Europe and
Asia. North America and Europe has a well-established pharmaceutical industry, which
has stimulated the growth of the respiratory inhaler device market in these regions. The
Asian market is expected to witness a double digit growth over the next five years, owing
to the flourishing pharmaceutical industry, development of healthcare infrastructure, and
rising disposable income.
Respiratory Inhaler Devices Market: Key Players
GlaxoSmithKline plc., Boehringer Ingelheim GmbH, AstraZeneca plc., Hospira Inc., Care
Fusion Corporation, 3M Company are some of the major key players in Respiratory
Inhaler devices global market.

Thank You!

To know more about us, please visit our website:

www.futuremarketinsights.com
For sales queries or new topics email us on:
sales@futuremarketinsights.com
For other queries contact: Mr. Sudip Saha
Future Market Insights: 616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States
T: +1-347-918-3531 | D: +1-845-579-5705